HS

Harchand Singh

Active Director Director DIN 11244332
DIN 11244332 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Harchand Singh

Data last updated:

Harchand Singh is a Director at Alpex Pharma Private Limited (since 2025). The company operates in Pharma. Alpex Pharma Private Limited reported revenue of ₹26.00 Cr (FY 2025).

DIN 11244332
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2025
Oldest Company Age 4 yrs
Largest company Alpex Pharma Private Limited · ₹26.00 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alpex Pharma Private Limited U24299HR2022PTC102687
Director01 Aug 20252022₹26.00 Cr (FY 2025)Active

Board colleagues of Harchand Singh

Directorship timeline

Open interactive timeline →
Alpex Pharma Private Limited
Premium access

Shareholding and investment profile for Harchand Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harchand Singh

Harchand Singh currently holds 1 directorship: Alpex Pharma Private Limited (Director, since 01 Aug 2025, revenue ₹26.00 Cr (FY 2025)).

Harchand Singh was first appointed on 01 Aug 2025 as Director at Alpex Pharma Private Limited.

The current boards of Harchand Singh's companies include Karamjeet Singh (Alpex Pharma Private Limited), Sanjay Mittal (Alpex Pharma Private Limited), Shubham Mittal (Alpex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available